Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Boehringer Ingelheim
Healthtrust
UBS
US Army

Generated: May 22, 2019

DrugPatentWatch Database Preview

Drug Price Trends for RIVASTIGMINE

« Back to Dashboard

Drug Price Trends for RIVASTIGMINE

Average Pharmacy Cost for RIVASTIGMINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
RIVASTIGMINE 9.5 MG/24HR PATCH 47781-0305-11 4.98357 EACH 2019-02-20
RIVASTIGMINE 1.5 MG CAPSULE 00904-6587-61 0.38189 EACH 2019-02-20
RIVASTIGMINE 1.5 MG CAPSULE 33342-0089-09 0.38189 EACH 2019-02-20
Drug Name NDC Price/Unit ($) Unit Date

Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for RIVASTIGMINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RIVASTIGMINE TARTRATE 1.5MG CAP Golden State Medical Supply, Inc. 60429-0393-60 60 46.06 0.76767 EACH 2018-01-01 - 2022-12-31 FSS
RIVASTIGMINE TARTRATE 3MG CAP Golden State Medical Supply, Inc. 60429-0394-60 60 34.69 0.57817 EACH 2018-01-01 - 2022-12-31 FSS
RIVASTIGMINE TARTRATE 4.5MG CAP Golden State Medical Supply, Inc. 60429-0395-60 60 36.41 0.60683 EACH 2018-01-01 - 2022-12-31 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
Mallinckrodt
McKinsey
Accenture
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.